Fit for purpose high‐throughput absolute quantitation of chimeric aducanumab in mouse cortex and plasma

Ähnliche Einträge

• Predicting differential effects of sex on therapeutic benefit and limitations in Alzheimer’s disease drug development using animal models
  von: Stacey J Sukoff Rizzo
  Veröffentlicht: (2025)
• Meeting report of the fifth annual workshop on Principles and Techniques for Improving Preclinical to Clinical Translation in Alzheimer's Disease Research
  von: Michael Sasner, et al.
  Veröffentlicht: (2024)
• Cell type specific contributions of mTOR inhibition that drive neuroprotective mechanisms in Alzheimer’s disease
  von: Kathryn A Haynes, et al.
  Veröffentlicht: (2024)
• Characterizing plasma biomarkers of Alzheimer’s disease in three non‐human primate species: marmosets, titi monkeys, and capuchins
  von: Emily S. Rothwell, et al.
  Veröffentlicht: (2024)
• Characterizing molecular and synaptic signatures in mouse models of late‐onset Alzheimer's disease independent of amyloid and tau pathology
  von: Kevin P. Kotredes, et al.
  Veröffentlicht: (2024)